Rosetta Genomics (ROSG) Keeps Momentum Going, Indicated Much Higher Early
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts ROSG Hot Sheet
Join SI Premium – FREE
Rosetta Genomics (Nasdaq: ROSG) is headed for another strong open Tuesday after a late-session dip last Friday. Market data has the stock up about 13 percent in pre-market trading.
Last week, the company announced a $6 million registered direct offering as well as the appointment of a new finance chief.
Last week, the company announced a $6 million registered direct offering as well as the appointment of a new finance chief.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zuckerberg: Meta has reached AI ‘frontier,’ rejects calls for slowdown
- Lumentum's optical components sold out through early 2029: CEO
- Starbucks (SBUX) isn't buying Chipotle Mexican Grill (CMG) - CNBC
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
